Ipamorelin 1mg/ CJC-1295 1mg (No DAC)

This research peptide blend combines Ipamorelin, a selective growth hormone secretagogue, with CJC-1295 (No DAC), a synthetic analog of growth hormone-releasing hormone (GHRH). Together, they are widely studied in vitro for their potential synergistic effects on GH-related signaling pathways without the long-acting modifications of DAC.

• Ipamorelin (1mg) is investigated for its targeted interaction with ghrelin receptors, promoting controlled GH release in lab environments.

• CJC-1295 No DAC (1mg) is researched for short-duration GH secretion stimulation in in vitro experiments, allowing researchers to isolate effects over shorter cycles.

This 1:1 blend is optimized for scientific studies requiring short-acting, well-defined peptide dynamics with consistent purity and concentration.

Disclaimer: Ipamorelin / CJC-1295 (No DAC) is intended for research purposes only. It is not for human or veterinary use, and not approved for diagnostic, therapeutic, or clinical applications.